Ra Medical Systems, Inc. (RMED)
| Market Cap | 20.35M |
| Revenue (ttm) | 4.58M |
| Net Income (ttm) | -35.34M |
| Shares Out | 2.39M |
| EPS (ttm) | -31.89 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $6.97 |
| Previous Close | $7.08 |
| Change ($) | -0.11 |
| Change (%) | -1.55% |
| Day's Open | 7.08 |
| Day's Range | 6.81 - 7.19 |
| Day's Volume | 273,459 |
| 52-Week Range | 4.39 - 62.25 |
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatologic...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserte...
The short term investor may want to consider this trio of companies
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems moves to the NYSE American.
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces the availability of its webcast event, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, di...
LOS ANGELES, Dec. 7, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc. ("Ra Medic...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) is hosting a webcast, The Inimitable Role of Excimer Lasers During the COVID-19 Pandemic, featuring Theodore J. Daly, M...
In this article we will check out the progression of hedge fund sentiment towards Ra Medical Systems, Inc. (NYSE:RMED) and determine whether it is a good investment right now. We at Insider Mo...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disea...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological disease...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announced today that its Board of Directors has approved a 1-for-25 reverse stock split of the Company's common stock, ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disea...
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2020 Results - Earnings Call Transcript
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseas...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical System to host webcast discussing the role of excimer lasers in the treatment of psoriasis during the pandemic
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report third quarter 2020 financial results and provide a business update after market close on ...
LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz continues its investigation of potential claims against the board of directors of Ra Medical Systems, Inc....
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological disease...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.
Ra Medical Systems, Inc. (RMED) CEO Jonathan McGuire on Q2 2020 Results - Earnings Call Transcript
Shares of Ra Medical Systems (NYSE:RMED) decreased 9.56% in after-market trading after the company reported Q2 results.
Ra Medical Systems, Inc. (RMED) delivered earnings and revenue surprises of -152.94% and 125.00%, respectively, for the quarter ended June 2020.
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc.
LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical”...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an...
NEW ORLEANS, May 22, 2020 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has ...
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2020 Results - Earnings Call Transcript
Ra Medical Systems Inc (RMED) delivered earnings and revenue surprises of -166.67% and -9.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for ...
These five stocks are poised to grow with the guidelines laid out to reopen the economy, as coronavirus pandemic dissipates.
Ra Medical Systems' (RMED) Management on Q4 2019 Results - Earnings Call Transcript
Ra Medical Systems' (RMED) CEO Dean Irwin on Q1 2019 Results - Earnings Call Transcript
Ra Medical Systems, Inc. (RMED) CEO Dean Irwin on Q4 2018 Results - Earnings Call Transcript
About RMED
Ra Medical Systems, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device ... [Read more...]
| Industry Medical Devices | IPO Date Aug 30, 2018 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol RMED |
Financial Performance
In 2019, RMED's revenue was $7.20 million, an increase of 15.06% compared to the previous year's $6.26 million. Losses were -$56.96 million, 84.7% more than in 2018.
Analyst Forecasts
According to 2 analysts, the average rating for RMED stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 129.56% from the latest price.